Eyegate Pharmaceuticals Inc Warrants 2015-2020 On Shs

( )
EYEGW After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
ICPTIntercept Pharmaceuticals, Inc.
AMRNAmarin Corporation Plc Sponsored ADR
SAGESAGE Therapeutics, Inc.
JAZZJazz Pharmaceuticals Plc
PRGOPerrigo Co. Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
CTLTCatalent Inc
PTLAPortola Pharmaceuticals, Inc.
UTHRUnited Therapeutics Corporation
HZNPHorizon Pharma plc
CORTCorcept Therapeutics Incorporated.
MDCOMedicines Company
AERIAerie Pharmaceuticals, Inc.
IRWDIronwood Pharmaceuticals, Inc. Class A

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.